Emulsion Systems for Nucleic Acid Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional BEAMing techniques for emulsion PCR are cumbersome and not adaptable for high-throughput analyses, requiring high input energy to generate effective emulsions and specialized machines, limiting their scalability and efficiency.

Innovation Solution

A method involving a mixture of an aqueous phase and an oil phase, emulsified through an orifice with controlled velocity and diameter to generate stable water-in-oil emulsions, using co-emulsifiers to reduce energy requirements, and new formulations for demulsification to facilitate efficient nucleic acid amplification and high-throughput analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional BEAMing techniques are used to generate emulsions for nucleic acid amplification, then effective emulsion formation is achieved, but high input energy and specialized machines are required

Engineering Contradiction:
Improveemulsion formation effectivenessVSAvoidinput energy for emulsion generation
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The patent changes the chemical parameters of the emulsion system by introducing specific co-emulsifiers (such as polyglyceryl-4 isostearate, cetyl PEG/PPG-10/1-dimethicone, and hexyl laurate) that work synergistically with primary emulsifiers to reduce the energy required for emulsion formation. This chemical parameter modification allows standard pipetting to achieve effective emulsification without specialized high-energy equipment

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces co-emulsifiers as intermediary substances that mediate between the aqueous and oil phases, facilitating emulsion formation with lower energy input. These co-emulsifiers act as bridges that reduce interfacial tension and enable stable emulsion formation through simple pipetting rather than requiring high-energy specialized machines

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional BEAMing techniques are used, then nucleic acid amplification can be performed, but the process is cumbersome and not adaptable for high-throughput analyses

Engineering Contradiction:
Improvenucleic acid amplificationVSAvoidhigh-throughput capability
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent modifies the physical parameters of the emulsion system by optimizing droplet size distribution and emulsion stability through the use of co-emulsifiers. This results in more uniform compartmentalization that is better suited for high-throughput automated analysis, enabling thousands of reactions to be processed in parallel with improved reproducibility

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates an emulsion system that serves multiple functions: it enables nucleic acid amplification, facilitates easy phase separation, and supports high-throughput processing. The new emulsion formulation can be used with standard laboratory equipment rather than specialized machines, making the technique universally applicable across different laboratory settings and scalable to high-throughput analyses

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Device complexity

If standard pipetting is used instead of specialized machines, then device complexity is reduced, but emulsion homogeneity and stability may be compromised

Engineering Contradiction:
Improveequipment requirementsVSAvoidemulsion homogeneity
Core Design Contradiction:
Device complexityVSStability of the object's composition

Solution Approach 1:

The patent changes the rheological and surface tension parameters of the emulsion system by incorporating co-emulsifiers with specific molecular structures. These substances optimize the flow properties and interfacial characteristics of the emulsion, allowing standard pipetting to generate homogeneous and stable droplets without requiring specialized high-shear mixing equipment

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a simple, disposable pipette-based approach instead of expensive, complex, and potentially contaminating specialized emulsion-generating machines. The co-emulsifier formulation enables this simpler, less expensive approach to produce emulsions with sufficient homogeneity and stability for reliable nucleic acid amplification

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the formation of homogenous emulsions with reduced energy input, allowing for high-throughput, reproducible nucleic acid analyses by BEAMing, without the need for specialized machines, and efficient recovery of beads, thus overcoming the limitations of previous methods.

Implementation Method 1

emulsifying the mixture by passing the mixture through an orifice having a diameter between 2 mm and 50 μm with a velocity of 40 μl/s to 220 μl/s to generate an emulsion

Methodology Applied
Scientific EffectHydrodynamic Cavitation: Hydrodynamic Cavitation

Implementation Method 2

using co-emulsifiers to reduce energy requirements

Methodology Applied
Scientific EffectSurfactant: Surfactant

Implementation Method 3

new formulations for demulsification to facilitate efficient nucleic acid amplification and high-throughput analysis

Methodology Applied
Scientific EffectDemulsification:

Data Source

PatentEP2912196B1Emulsion systems for emulsion-based amplification of nucleic acid
Publication Date: 2018.08.08 SYSMEX CORP
  • EP2912196B1 patent drawingFigure 1
  • EP2912196B1 patent drawingFigure 2
  • EP2912196B1 patent drawingFigure 3

AI summary

Methods for efficient and high throughput emulsion-based nucleic amplification are provided. In some aspects, emulsion mixtures are provided that require extremely low input energy (e.g., the energy generated by pipetting) to form emulsions that are effective for nucleic acid amplification. Efficient formulations for breaking emulsions are likewise provided.